THE COMPREHENSIVE COMPARISON OF THE EFFICACY OF FIRST-LINE DRUGS IN THE TREATMENT OF TYPE II DIABETES: METFORMIN, GLP-1 AGONISTS, AND SGLT2 INHIBITORS. IJITSS [Internet]. 2025 Sep. 30 [cited 2026 Mar. 17];6(3(47). Available from: https://rspublisher.org/index.php/ijitss/article/view/3884